Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›KraneShares›KURE

KURE

KraneShares MSCI All China Health Care Index ETF

Passive ETF Equity

KURE ETF · KraneShares MSCI All China Health Care Index UCITS ETF

The KURE Exchange Traded Fund (ETF) is provided by KraneShares. It is built to track an index: MSCI China All Shares Health Care 10/40 Index. The KURE ETF provides physical exposure, so by buying it you actually own parts of all the 81 underlying holdings. The dividend policy is capitalization.

$17.28

+$0.01 (+0.06%) yesterday

1:30 PM 07/31/26 Closed

1D price range

$17.13$17.32

52W price range

$14.59$21.65

YTD Perf.

+0.17%

YTD Flows

Annualized volatility

Fund AuM

€86M

Share class AuM

€86M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US5007678353

TER

0.79%

Inception date

1/31/2018

Issuer

KraneShares

Benchmark

MSCI China All Shares Health Care 10/40 Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
371470 Mirae Asset TIGER Biotech Solactive ETF	-3.37%
09820 Global X China Biotech ETF	-
MCHI iShares MSCI China ETF	+3.79%
FXI iShares China Large-Cap ETF	+5.86%
CQQQ Invesco China Technology ETF	-1.48%
ASHR Xtrackers Harvest CSI 300 China A-Shares ETF	-3.15%
EWH iShares MSCI Hong Kong ETF	+3.54%
CXSE WisdomTree China ex-State-Owned Enterprises Fund	-1.69%
GXC State Street SPDR S&P China ETF	+0.91%
FLCH Franklin FTSE China ETF	+1.57%
CNYA iShares MSCI China A ETF	-1.66%
KBA KraneShares Bosera MSCI China A 50 Connect Index ETF	-3.19%
CHIQ Global X MSCI China Consumer Discretionary ETF	+5.02%
CNXT VanEck ChiNext Innovators ETF	-6.73%
PGJ Invesco Golden Dragon China ETF	+5.83%

API

PerformanceDec 31, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

98.15%

Unavailable

0.27%

Other

1.58%

Latest KURE news

Chinese ETFs Surge as Beijing Pledges More Support

Moving Markets · February 13, 2024

FAQ about KURE

KURE is a Passive ETF. This ETF provides exposure to Large and Mid-Cap Chinese Health Care Equities.

KURE tracks the MSCI China All Shares Health Care 10/40 Index - USD, through a full replication replication method.

KURE carries a total expense ratio (TER) of 0.79%, indicating the annual cost for holding the fund.

KURE was introduced to the market on January 31, 2018. It trades on United States Minor Outlying Islands, among other exchanges

KraneShares MSCI All China Health Care Index ETF, KURE, is provided by KraneShares. Learn more about KraneShares here.

KURE oversees €86M in assets as of July 30, 2026.

KURE follows a distributing dividend policy, meaning it pays out income to investors. As of July 30, 2026, its 12-month trailing yield was 4.16%.

As of June 30, 2026, KURE has significant geographic allocations in China, Switzerland and Hong Kong.

As of June 30, 2026, KURE focuses largely on Healthcare.

As of June 30, 2026, KURE holds 45 positions in its portfolio, with 65.95% of assets concentrated in its top 15 holdings.

As of June 30, 2026, KURE top three holdings include BeOne Medicines Ltd., Innovent Biologics, Inc. and WuXi Biologics (Cayman), Inc..

The base currency of KURE is USD.

Top 10 holdings

Data as of 06/30/26

BeOne Medicines Ltd.

8.84%

Innovent Biologics, Inc.

8.80%

WuXi Biologics (Cayman), Inc.

7.51%

WuXi AppTec Co., Ltd.

5.79%

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

4.59%

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

4.27%

Akeso, Inc.

3.72%

CSPC Pharmaceutical Group Ltd.

3.68%

Sino Biopharmaceutical Ltd.

3.39%

WuXi AppTec Co., Ltd.

3.35%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

KraneShares MSCI All China Health Care Index ETF

FAQ about KURE

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US